122 related articles for article (PubMed ID: 27846736)
41. Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth.
Smith SA; Burton SL; Kilembe W; Lakhi S; Karita E; Price M; Allen S; Hunter E; Derdeyn CA
PLoS Pathog; 2016 Nov; 12(11):e1005989. PubMed ID: 27851829
[TBL] [Abstract][Full Text] [Related]
42. Effect of HIV-1 Env on SERINC5 Antagonism.
Beitari S; Ding S; Pan Q; Finzi A; Liang C
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928004
[TBL] [Abstract][Full Text] [Related]
43. Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.
Lorenzi JC; Cohen YZ; Cohn LB; Kreider EF; Barton JP; Learn GH; Oliveira T; Lavine CL; Horwitz JA; Settler A; Jankovic M; Seaman MS; Chakraborty AK; Hahn BH; Caskey M; Nussenzweig MC
Proc Natl Acad Sci U S A; 2016 Dec; 113(49):E7908-E7916. PubMed ID: 27872306
[TBL] [Abstract][Full Text] [Related]
44. HIV Broadly Neutralizing Antibodies: Taking Good Care Of The 98.
Sok D; Burton DR
Immunity; 2016 Nov; 45(5):958-960. PubMed ID: 27851923
[TBL] [Abstract][Full Text] [Related]
45. Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity.
Lorin V; Malbec M; Eden C; Bruel T; Porrot F; Seaman MS; Schwartz O; Mouquet H
Mucosal Immunol; 2017 May; 10(3):814-826. PubMed ID: 27966557
[TBL] [Abstract][Full Text] [Related]
46. Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects.
Huang Y; Ferrari G; Alter G; Forthal DN; Kappes JC; Lewis GK; Love JC; Borate B; Harris L; Greene K; Gao H; Phan TB; Landucci G; Goods BA; Dowell KG; Cheng HD; Bailey-Kellogg C; Montefiori DC; Ackerman ME
J Immunol; 2016 Dec; 197(12):4603-4612. PubMed ID: 27913647
[TBL] [Abstract][Full Text] [Related]
47. Impact of Chronic HIV/SIV Infection on T Follicular Helper Cell Subsets and Germinal Center Homeostasis.
Graff-Dubois S; Rouers A; Moris A
Front Immunol; 2016; 7():501. PubMed ID: 27891132
[TBL] [Abstract][Full Text] [Related]
48. Structure of the transmembrane domain of HIV-1 envelope glycoprotein.
Chen B; Chou JJ
FEBS J; 2017 Apr; 284(8):1171-1177. PubMed ID: 27868386
[TBL] [Abstract][Full Text] [Related]
49. Enhancing Virion Tethering by BST2 Sensitizes Productively and Latently HIV-infected T cells to ADCC Mediated by Broadly Neutralizing Antibodies.
Pham TN; Lukhele S; Dallaire F; Perron G; Cohen ÉA
Sci Rep; 2016 Nov; 6():37225. PubMed ID: 27853288
[TBL] [Abstract][Full Text] [Related]
50. HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.
Bradley T; Yang G; Ilkayeva O; Holl TM; Zhang R; Zhang J; Santra S; Fox CB; Reed SG; Parks R; Bowman CM; Bouton-Verville H; Sutherland LL; Scearce RM; Vandergrift N; Kepler TB; Moody MA; Liao HX; Alam SM; McLendon R; Everitt JI; Newgard CB; Verkoczy L; Kelsoe G; Haynes BF
J Immunol; 2016 Dec; 197(12):4663-4673. PubMed ID: 27849170
[TBL] [Abstract][Full Text] [Related]
51. BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.
Richard J; Prévost J; von Bredow B; Ding S; Brassard N; Medjahed H; Coutu M; Melillo B; Bibollet-Ruche F; Hahn BH; Kaufmann DE; Smith AB; Sodroski J; Sauter D; Kirchhoff F; Gee K; Neil SJ; Evans DT; Finzi A
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331088
[TBL] [Abstract][Full Text] [Related]
52. Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses.
Prévost J; Zoubchenok D; Richard J; Veillette M; Pacheco B; Coutu M; Brassard N; Parsons MS; Ruxrungtham K; Bunupuradah T; Tovanabutra S; Hwang KK; Moody MA; Haynes BF; Bonsignori M; Sodroski J; Kaufmann DE; Shaw GM; Chenine AL; Finzi A
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100618
[TBL] [Abstract][Full Text] [Related]
53. Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection.
Adnan S; Reeves RK; Gillis J; Wong FE; Yu Y; Camp JV; Li Q; Connole M; Li Y; Piatak M; Lifson JD; Li W; Keele BF; Kozlowski PA; Desrosiers RC; Haase AT; Johnson RP
PLoS Pathog; 2016 Dec; 12(12):e1006104. PubMed ID: 27959961
[TBL] [Abstract][Full Text] [Related]
54. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
55. Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses.
Tomusange K; Wijesundara D; Gummow J; Wesselingh S; Suhrbier A; Gowans EJ; Grubor-Bauk B
Sci Rep; 2016 Nov; 6():36658. PubMed ID: 27853256
[TBL] [Abstract][Full Text] [Related]
56. Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.
Pincus SH; Song K; Maresh GA; Hamer DH; Dimitrov DS; Chen W; Zhang MY; Ghetie VF; Chan-Hui PY; Robinson JE; Vitetta ES
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852851
[TBL] [Abstract][Full Text] [Related]
57. Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.
Pacheco B; Alsahafi N; Debbeche O; Prévost J; Ding S; Chapleau JP; Herschhorn A; Madani N; Princiotto A; Melillo B; Gu C; Zeng X; Mao Y; Smith AB; Sodroski J; Finzi A
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003492
[TBL] [Abstract][Full Text] [Related]
58. Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques.
Luo K; Liao HX; Zhang R; Easterhoff D; Wiehe K; Gurley TC; Armand LC; Allen AA; Von Holle TA; Marshall DJ; Whitesides JF; Pritchett J; Foulger A; Hernandez G; Parks R; Lloyd KE; Stolarchuk C; Sawant S; Peel J; Yates NL; Dunford E; Arora S; Wang A; Bowman CM; Sutherland LL; Scearce RM; Xia SM; Bonsignori M; Pollara J; Edwards RW; Santra S; Letvin NL; Tartaglia J; Francis D; Sinangil F; Lee C; Kaewkungwal J; Nitayaphan S; Pitisuttithum P; Rerks-Ngarm S; Michael NL; Kim JH; Alam SM; Vandergrift NA; Ferrari G; Montefiori DC; Tomaras GD; Haynes BF; Moody MA
JCI Insight; 2016 Dec; 1(20):e88522. PubMed ID: 27942585
[TBL] [Abstract][Full Text] [Related]
59. Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins.
Zoubchenok D; Veillette M; Prévost J; Sanders-Buell E; Wagh K; Korber B; Chenine AL; Finzi A
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928014
[TBL] [Abstract][Full Text] [Related]
60. Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection.
Astronomo RD; Santra S; Ballweber-Fleming L; Westerberg KG; Mach L; Hensley-McBain T; Sutherland L; Mildenberg B; Morton G; Yates NL; Mize GJ; Pollara J; Hladik F; Ochsenbauer C; Denny TN; Warrier R; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Ferrari G; Shaw GM; Xia SM; Liao HX; Montefiori DC; Tomaras GD; Haynes BF; McElrath JM
EBioMedicine; 2016 Dec; 14():97-111. PubMed ID: 27919754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
